tirzepatide glp-1 Explained: The Future of Weight Management Structures of (a) GLP-1, (b)
Description
Pfizer has said it expects pills to eventually capture about a third of the obesity drug market, which is predicted to grow to about $130 billion by the end of the decade.
Eli Lilly and Novo Nordisk are closing in on deals with the Trump administration that would exchange deep discounts on their weight loss drugs for coverage under Medicare, per Endpoints News
Plant-based and vegan
Discover how GLP-1RAs reduce external eating behavior and improve appetite and glucose control in people with type 2 diabetes.
Doctor's Tips
